vs
Personalis, Inc.（PSNL）与RIVERVIEW BANCORP INC（RVSB）财务数据对比。点击上方公司名可切换其他公司
Personalis, Inc.的季度营收约是RIVERVIEW BANCORP INC的1.2倍（$17.3M vs $14.0M），RIVERVIEW BANCORP INC净利率更高（9.8% vs -137.3%，领先147.1%），RIVERVIEW BANCORP INC同比增速更快（10.4% vs 3.2%），RIVERVIEW BANCORP INC自由现金流更多（$-736.0K vs $-22.3M），过去两年RIVERVIEW BANCORP INC的营收复合增速更高（24.6% vs -5.7%）
Personalis, Inc.是一家专注于肿瘤领域先进基因组学解决方案的精准医疗企业，开发专有基因组测序及数据分析平台，为生物制药合作伙伴的免疫疗法研发、临床机构的个性化癌症诊疗提供支持，业务覆盖北美、欧洲及亚太核心市场。
Riverview Bancorp Inc.是一家总部位于美国的银行控股公司，主营个人与商业银行业务，服务覆盖太平洋西北地区，提供存款、消费贷款、住房抵押贷款、商业信贷及小企业金融等产品，服务零售客户与本地企业群体。
PSNL vs RVSB — 直观对比
营收规模更大
PSNL
是对方的1.2倍
$14.0M
营收增速更快
RVSB
高出7.1%
3.2%
净利率更高
RVSB
高出147.1%
-137.3%
自由现金流更多
RVSB
多$21.6M
$-22.3M
两年增速更快
RVSB
近两年复合增速
-5.7%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $17.3M | $14.0M |
| 净利润 | $-23.8M | $1.4M |
| 毛利率 | 11.0% | — |
| 营业利润率 | -145.7% | 12.4% |
| 净利率 | -137.3% | 9.8% |
| 营收同比 | 3.2% | 10.4% |
| 净利润同比 | -45.0% | 11.8% |
| 每股收益（稀释后） | $-0.26 | $0.07 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PSNLRVSB
| Q4 25 | $17.3M | $14.0M | ||
| Q3 25 | $14.5M | $13.6M | ||
| Q2 25 | $17.2M | $13.3M | ||
| Q1 25 | $20.6M | $12.9M | ||
| Q4 24 | $16.8M | $12.7M | ||
| Q3 24 | $25.7M | $12.8M | ||
| Q2 24 | $22.6M | $12.2M | ||
| Q1 24 | $19.5M | $9.0M |
净利润PSNLRVSB
| Q4 25 | $-23.8M | $1.4M | ||
| Q3 25 | $-21.7M | $1.1M | ||
| Q2 25 | $-20.1M | $1.2M | ||
| Q1 25 | $-15.8M | $1.1M | ||
| Q4 24 | $-16.4M | $1.2M | ||
| Q3 24 | $-39.1M | $1.6M | ||
| Q2 24 | $-12.8M | $966.0K | ||
| Q1 24 | $-13.0M | $-3.0M |
毛利率PSNLRVSB
| Q4 25 | 11.0% | — | ||
| Q3 25 | 13.2% | — | ||
| Q2 25 | 27.6% | — | ||
| Q1 25 | 35.0% | — | ||
| Q4 24 | 27.1% | — | ||
| Q3 24 | 34.0% | — | ||
| Q2 24 | 35.6% | — | ||
| Q1 24 | 28.1% | — |
营业利润率PSNLRVSB
| Q4 25 | -145.7% | 12.4% | ||
| Q3 25 | -160.7% | 10.2% | ||
| Q2 25 | -126.7% | 11.7% | ||
| Q1 25 | -85.9% | 11.3% | ||
| Q4 24 | -107.8% | 12.4% | ||
| Q3 24 | -55.9% | 15.5% | ||
| Q2 24 | -74.8% | 10.0% | ||
| Q1 24 | -96.7% | -47.5% |
净利率PSNLRVSB
| Q4 25 | -137.3% | 9.8% | ||
| Q3 25 | -149.4% | 8.1% | ||
| Q2 25 | -116.6% | 9.2% | ||
| Q1 25 | -76.4% | 8.9% | ||
| Q4 24 | -97.8% | 9.7% | ||
| Q3 24 | -152.0% | 12.2% | ||
| Q2 24 | -56.7% | 7.9% | ||
| Q1 24 | -66.4% | -34.7% |
每股收益（稀释后）PSNLRVSB
| Q4 25 | $-0.26 | $0.07 | ||
| Q3 25 | $-0.24 | $0.05 | ||
| Q2 25 | $-0.23 | $0.06 | ||
| Q1 25 | $-0.18 | $0.05 | ||
| Q4 24 | $-0.23 | $0.06 | ||
| Q3 24 | $-0.64 | $0.07 | ||
| Q2 24 | $-0.24 | $0.05 | ||
| Q1 24 | $-0.26 | $-0.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $240.0M | $28.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $261.2M | $164.2M |
| 总资产 | $334.2M | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PSNLRVSB
| Q4 25 | $240.0M | $28.6M | ||
| Q3 25 | $150.5M | $32.8M | ||
| Q2 25 | $173.2M | $34.2M | ||
| Q1 25 | $185.7M | $29.4M | ||
| Q4 24 | $185.0M | $25.3M | ||
| Q3 24 | $143.7M | $31.0M | ||
| Q2 24 | $87.0M | $27.8M | ||
| Q1 24 | $95.4M | $23.6M |
股东权益PSNLRVSB
| Q4 25 | $261.2M | $164.2M | ||
| Q3 25 | $171.4M | $163.5M | ||
| Q2 25 | $190.8M | $162.0M | ||
| Q1 25 | $207.3M | $160.0M | ||
| Q4 24 | $203.0M | $158.3M | ||
| Q3 24 | $166.8M | $160.8M | ||
| Q2 24 | $112.3M | $155.9M | ||
| Q1 24 | $120.7M | $155.6M |
总资产PSNLRVSB
| Q4 25 | $334.2M | $1.5B | ||
| Q3 25 | $242.8M | $1.5B | ||
| Q2 25 | $258.7M | $1.5B | ||
| Q1 25 | $273.3M | $1.5B | ||
| Q4 24 | $270.3M | $1.5B | ||
| Q3 24 | $239.9M | $1.5B | ||
| Q2 24 | $185.5M | $1.5B | ||
| Q1 24 | $195.3M | $1.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $-506.0K |
| 自由现金流经营现金流 - 资本支出 | $-22.3M | $-736.0K |
| 自由现金流率自由现金流/营收 | -128.7% | -5.2% |
| 资本支出强度资本支出/营收 | 0.4% | 1.6% |
| 现金转化率经营现金流/净利润 | — | -0.37× |
| 过去12个月自由现金流最近4个季度 | $-79.5M | $20.4M |
8季度趋势，按日历期对齐
经营现金流PSNLRVSB
| Q4 25 | $-22.2M | $-506.0K | ||
| Q3 25 | $-21.8M | $16.8M | ||
| Q2 25 | $-12.9M | $-697.0K | ||
| Q1 25 | $-18.0M | $8.3M | ||
| Q4 24 | $-7.8M | $2.2M | ||
| Q3 24 | $-6.2M | $764.0K | ||
| Q2 24 | $-10.7M | $5.4M | ||
| Q1 24 | $-20.4M | $12.8M |
自由现金流PSNLRVSB
| Q4 25 | $-22.3M | $-736.0K | ||
| Q3 25 | $-23.4M | $16.4M | ||
| Q2 25 | $-13.2M | $-773.0K | ||
| Q1 25 | $-20.5M | $5.6M | ||
| Q4 24 | $-9.0M | $1.9M | ||
| Q3 24 | $-6.4M | $-1.4M | ||
| Q2 24 | $-10.7M | $5.3M | ||
| Q1 24 | $-20.5M | $7.1M |
自由现金流率PSNLRVSB
| Q4 25 | -128.7% | -5.2% | ||
| Q3 25 | -161.6% | 120.1% | ||
| Q2 25 | -76.9% | -5.8% | ||
| Q1 25 | -99.4% | 43.1% | ||
| Q4 24 | -53.8% | 15.0% | ||
| Q3 24 | -25.1% | -11.3% | ||
| Q2 24 | -47.6% | 43.7% | ||
| Q1 24 | -105.1% | 79.0% |
资本支出强度PSNLRVSB
| Q4 25 | 0.4% | 1.6% | ||
| Q3 25 | 11.2% | 2.9% | ||
| Q2 25 | 1.7% | 0.6% | ||
| Q1 25 | 12.2% | 21.0% | ||
| Q4 24 | 7.4% | 2.4% | ||
| Q3 24 | 1.0% | 17.3% | ||
| Q2 24 | 0.0% | 0.9% | ||
| Q1 24 | 0.5% | 62.0% |
现金转化率PSNLRVSB
| Q4 25 | — | -0.37× | ||
| Q3 25 | — | 15.25× | ||
| Q2 25 | — | -0.57× | ||
| Q1 25 | — | 7.20× | ||
| Q4 24 | — | 1.79× | ||
| Q3 24 | — | 0.49× | ||
| Q2 24 | — | 5.63× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PSNL
| Population Sequencing | $11.8M | 68% |
| Related Party | $5.4M | 31% |
RVSB
暂无分部数据
